LANSDOWNE PARTNERS (UK) LLP - Q1 2019 holdings

$4.51 Billion is the total value of LANSDOWNE PARTNERS (UK) LLP's 119 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 0.0% .

 Value Shares↓ Weighting
OIH  VANECK VECTORS ETF TRcall$6,892,000
+22.8%
400,0000.0%0.15%
+84.3%
SMMT  SUMMIT THERAPEUTICS PLCspons ads$2,922,000
+59.2%
1,596,6660.0%0.06%
+140.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DELTA AIR LINES INC DEL38Q3 202325.1%
EATON CORP PLC33Q3 202311.6%
TAIWAN SEMICONDUCTOR MFG LTD25Q3 202317.9%
MANCHESTER UTD PLC NEW22Q3 20191.0%
SUMMIT THERAPEUTICS PLC22Q2 20200.6%
AMAZON COM INC21Q3 202313.9%
JPMORGAN CHASE & CO20Q1 201919.9%
CITIGROUP INC20Q4 202012.2%
FIRST SOLAR INC20Q3 20214.2%
UNITED TECHNOLOGIES CORP20Q1 20203.7%

View LANSDOWNE PARTNERS (UK) LLP's complete holdings history.

Latest significant ownerships (13-D/G)
LANSDOWNE PARTNERS (UK) LLP Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Supernova Partners Acquisition Co II, Ltd.February 14, 20222,152,9116.2%
Summit Therapeutics plcJune 17, 202013,664,8804.1%
Manchester United plcSold outFebruary 14, 202000.0%
CYTOKINETICS INCJanuary 30, 20182,647,9814.9%
RESPONSE GENETICS INCSold outFebruary 12, 201600.0%

View LANSDOWNE PARTNERS (UK) LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-10
SC 13G2023-02-08
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-16

View LANSDOWNE PARTNERS (UK) LLP's complete filings history.

Compare quarters

Export LANSDOWNE PARTNERS (UK) LLP's holdings